Director, U.S Customer Engagement, Strategic Alliances and Advocacy
OtherRemoteUSAUSD 235K–USD 255K3 days ago
Company identity and hiring signals verified from public source listings
Observed daily snapshots
Latest: 31 roles
Observed active listings increased from 4 to 31 across 21 snapshot days. Missing days are left as gaps and are not estimated.
| Date | Active listings |
|---|---|
| 2026-08-31 | 4 |
| 2026-09-01 | 4 |
| 2026-09-02 | 4 |
| 2026-09-03 | 4 |
| 2026-09-04 | 40 |
| 2026-09-05 | 39 |
| 2026-09-06 | 39 |
| 2026-09-07 | 39 |
| 2026-09-08 | 39 |
| 2026-09-09 | 39 |
| 2026-09-11 | 40 |
| 2026-09-13 | 39 |
| 2026-09-15 | 43 |
| 2026-09-28 | 33 |
| 2026-10-04 | 31 |
| 2026-10-11 | 34 |
| 2026-10-13 | 33 |
| 2026-10-16 | 31 |
| 2026-10-19 | 33 |
| 2026-10-22 | 25 |
| 2026-10-25 | 31 |
Listing recency
Source observation shows when Base Career last saw listings at their source. It does not mean every listing was revalidated within the last 24 hours.
Based on n=31 classified listings
Based on n=31 classified listings
Based on n=20 classified listings
Based on n=31 classified listings
| Seniority | Median range | Sample |
|---|---|---|
| Senior | USD 200K–USD 218K / yearly | n=12 |
Verified active listings
OtherRemoteUSAUSD 235K–USD 255K3 days ago
HealthcareRemoteUSAUSD 145K–USD 165K6 days ago
HealthcareRemoteIndianapolisUSD 200K–USD 220K1 weeks ago
HealthcareRemoteUSAUSD 280K–USD 300K1 weeks ago
LogisticsOnsitePhiladelphia, PA1 weeks ago
OperationsOnsitePhiladelphia, Pennsylvania2 weeks ago
OtherPhiladelphia1 months ago
EngineeringPhiladelphia1 months ago
OtherSan Carlos1 months ago
OtherUSA1 months ago
HealthcareDallas1 months ago
OperationsPhiladelphia1 months ago
OtherPhiladelphia1 months ago
MarketingUSA3 months ago
OtherUSA4 months ago
OtherUSA4 months ago
OtherUSA6 months ago
HealthcareRemoteUnited StatesUSD 185K–USD 210K / yearly
SalesRemoteNebraska or North Dakota or South Dakota or IowaUSD 200K–USD 220K / yearly
OperationsRemoteUnited StatesUSD 270K–USD 290K / yearly
Public biopharmaceutical company developing and commercializing personalized tumor-infiltrating lymphocyte therapies for cancer patients.